Achieve Life Sciences Inc Hares (NASDAQ:ACHV) Short Interest Decreased By 1.88%

The stock of Achieve Life Sciences Inc Hares (NASDAQ:ACHV) registered a decrease of 1.88% in short interest. ACHV’s total short interest was 292,700 shares in July as published by FINRA. Its down 1.88% from 298,300 shares, reported previously. With 80,800 shares average volume, it will take short sellers 4 days to cover their ACHV’s short positions. The short interest to Achieve Life Sciences Inc Hares’s float is 4.98%.

The stock decreased 0.56% or $0.01 during the last trading session, reaching $1.76. About 95,432 shares traded. Achieve Life Sciences, Inc. (NASDAQ:ACHV) has declined 63.62% since July 14, 2018 and is downtrending. It has underperformed by 68.05% the S&P500.

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. The company has market cap of $13.77 million. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. It currently has negative earnings.

More notable recent Achieve Life Sciences, Inc. (NASDAQ:ACHV) news were published by: Streetinsider.com which released: “Achieve Life Sciences (ACHV) Prices $5.6 Million Registered Direct Offering of Common Stock, Warrants – StreetInsider.com” on October 01, 2018, also Seekingalpha.com with their article: “Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” published on November 07, 2018, Seekingalpha.com published: “Achieve Life Sciences up 38% premarket on performance of new cytisine formulation – Seeking Alpha” on September 27, 2018. More interesting news about Achieve Life Sciences, Inc. (NASDAQ:ACHV) were released by: Investorplace.com and their article: “Achieve Life Sciences Stock Will Probably Tumble Further – Investorplace.com” published on October 03, 2018 as well as Benzinga.com‘s news article titled: “Mid-Day Market Update: Crude Oil Down 2.5%; Titan Pharmaceuticals Shares Spike Higher – Benzinga” with publication date: February 25, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.